Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTN3 antisense RNA 1 (ACTN3-AS1) is a long non-coding RNA transcribed from the genome in the region antisense to the *ACTN3* gene. Antisense RNAs such as ACTN3-AS1 can regulate the expression of their sense counterparts at the level of transcription or translation. While regulation by antisense RNA is well-described in various systems, specific data on ACTN3-AS1’s biological function, disease association, or druggability is limited to database entries and general knowledge of antisense mechanisms. As a non-coding RNA, ACTN3-AS1 is fundamentally different from a typical drug target (like a receptor or enzyme) and mainly functions in gene expression regulation, potentially affecting the expression or processing of ACTN3 mRNA, but its therapeutic relevance remains largely unexplored. ACTN3-AS1 is correctly identified as a non-coding antisense RNA. It is not an established therapeutic target and has no direct drug interactions known. Its main role is gene regulation; specific roles in disease or therapy are not described in current literature.
Acts by non-coding RNA-based regulation of gene expression, not as a receptor, enzyme, or protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTN3 antisense RNA 1 (ACTN3-AS1).